Serum midkine as a surrogate biomarker for metastatic prediction in differentiated thyroid cancer patients with positive thyroglobulin antibody.
about
Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer.The Role of Midkine in Arteriogenesis, Involving Mechanosensing, Endothelial Cell Proliferation, and VasodilationChanges of serum midkine as a dynamic prognostic factor to monitor disease status in papillary thyroid cancer
P2860
Serum midkine as a surrogate biomarker for metastatic prediction in differentiated thyroid cancer patients with positive thyroglobulin antibody.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum midkine as a surrogate b ...... sitive thyroglobulin antibody.
@en
Serum midkine as a surrogate b ...... sitive thyroglobulin antibody.
@nl
type
label
Serum midkine as a surrogate b ...... sitive thyroglobulin antibody.
@en
Serum midkine as a surrogate b ...... sitive thyroglobulin antibody.
@nl
prefLabel
Serum midkine as a surrogate b ...... sitive thyroglobulin antibody.
@en
Serum midkine as a surrogate b ...... sitive thyroglobulin antibody.
@nl
P2093
P2860
P356
P1433
P1476
Serum midkine as a surrogate b ...... sitive thyroglobulin antibody.
@en
P2093
Arun Upadhyaya
Chunmei Zhang
Guizhi Zhang
Huiying Wang
Pingping Zhou
P2860
P2888
P356
10.1038/SREP43516
P407
P577
2017-02-27T00:00:00Z